D. Mignard

609 total citations
10 papers, 442 citations indexed

About

D. Mignard is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, D. Mignard has authored 10 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in D. Mignard's work include Cancer therapeutics and mechanisms (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (4 papers). D. Mignard is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (4 papers). D. Mignard collaborates with scholars based in France and Belgium. D. Mignard's co-authors include Gilles Vassal, Patrice Herait, M. Bonnay, Caroline Germa, Claudia Côté, Mondher Mahjoubi, Faouzi Saliba, G. Bastian, J. L. Misset and Esteban Cvitkovic and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

D. Mignard

10 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Mignard France	7	289	216	92	83	79	10	442
Mona Patel United States	9	137 0.5×	119 0.6×	161 1.8×	50 0.6×	23 0.3×	19	423
Surbhi Agrawal United States	8	116 0.4×	173 0.8×	37 0.4×	70 0.8×	27 0.3×	27	376
Atsushi Ishiguro Japan	14	207 0.7×	230 1.1×	181 2.0×	162 2.0×	28 0.4×	50	567
Shinya Kajiura Japan	12	239 0.8×	60 0.3×	215 2.3×	150 1.8×	53 0.7×	72	468
Stephen H. Rosenoff United States	11	141 0.5×	78 0.4×	81 0.9×	90 1.1×	12 0.2×	16	417
Nitika Sharma United States	9	277 1.0×	109 0.5×	164 1.8×	17 0.2×	15 0.2×	18	488
Tetsuo Ishizaki Japan	11	262 0.9×	111 0.5×	116 1.3×	180 2.2×	17 0.2×	78	508
Frank Seebach United States	9	166 0.6×	106 0.5×	92 1.0×	80 1.0×	64 0.8×	37	407
Zhao Yin-nong China	10	114 0.4×	156 0.7×	42 0.5×	99 1.2×	85 1.1×	24	406
Lorenzo Camellini Italy	14	210 0.7×	91 0.4×	147 1.6×	200 2.4×	132 1.7×	27	590

Countries citing papers authored by D. Mignard

Since Specialization

Citations

This map shows the geographic impact of D. Mignard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Mignard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Mignard more than expected).

Fields of papers citing papers by D. Mignard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Mignard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Mignard. The network helps show where D. Mignard may publish in the future.

Co-authorship network of co-authors of D. Mignard

This figure shows the co-authorship network connecting the top 25 collaborators of D. Mignard. A scholar is included among the top collaborators of D. Mignard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Mignard. D. Mignard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Boige, Valérie, Julien Taı̈eb, Mohamed Hebbar, et al.. (2006). Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: A multicenter phase II study with dose adjustment according to baseline serum bilirubin level. European Journal of Cancer. 42(4). 456–459. 51 indexed citations

Boige, Valérie, Julien Taı̈eb, Mohamed Hebbar, et al.. (2004). Final results of a multicenter phase II study of irinotecan (CPT-11) in patients (pts) with advanced hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 22(14_suppl). 4180–4180. 2 indexed citations

Vassal, Gilles, François Doz, Didier Frappaz, et al.. (2003). A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors. Journal of Clinical Oncology. 21(20). 3844–3852. 82 indexed citations

Bécouarn, Y., Érick Gamelin, Bruno Coudert, et al.. (2001). Randomized Multicenter Phase II Study Comparing a Combination of Fluorouracil and Folinic Acid and Alternating Irinotecan and Oxaliplatin With Oxaliplatin and Irinotecan in Fluorouracil-Pretreated Metastatic Colorectal Cancer Patients. Journal of Clinical Oncology. 19(22). 4195–4201. 50 indexed citations

Ychou, Marc, Jean-Yves Douillard, Philippe Rougier, et al.. (2000). Randomized Comparison of Prophylactic Antidiarrheal Treatment Versus No Prophylactic Antidiarrheal Treatment in Patients Receiving CPT-11 (Irinotecan) for Advanced 5-FU-Resistant Colorectal Cancer. American Journal of Clinical Oncology. 23(2). 143–148. 22 indexed citations

Freyer, Gilles, P Rougier, R. Bugat, et al.. (2000). Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. British Journal of Cancer. 83(4). 431–437. 70 indexed citations

Raymond, Éric, Laurent Vernillet, Valérie Boige, et al.. (1999). Phase I dose finding study with irinotecan (CPT-11) in cancer patients (pts) with hepatic dysfynction. European Journal of Cancer. 35. S283–S284. 1 indexed citations

Lhommé, Catherine, P. Fumoleau, P. Fargeot, et al.. (1999). Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group Phase II Trial of First-Line Irinotecan in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Cervix. Journal of Clinical Oncology. 17(10). 3136–3142. 49 indexed citations

Saliba, Faouzi, J. L. Misset, G. Bastian, et al.. (1998). Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.. Journal of Clinical Oncology. 16(8). 2745–2751. 112 indexed citations

10.

Ychou, Marc, Jean‐François Seitz, M. Bonnay, et al.. (1997). Phase I/II study of CPT-11 in combination with LV2FU5 (De Gramont-Regimen) every 2 weeks for the treatment of colorectal cancer (CRC) after 5FU failure. European Journal of Cancer. 33. S169–S169. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact